Traditional clinical trials exclude more than 90 percent of patients and providers because of geographic and access barriers. This leads to study delays, excessive costs, and underrepresentation of diverse patient populations.
Learn how the Science 37 Metasite allows patients and providers access to clinical trials - no matter their geographic location*. Whether delivered as a stand-alone site, alongside traditional physical sites or to be deployed quickly for a rescue study—the Metasite allows sponsors and contract research organizations (CROs) to accelerate study timelines by:
- Expediting recruitment and enrollment
- Improving data quality, and enhancing the patient experience
- Delivering a more diverse patient population to clinical trials